Four things to know:
1. The global spinal fusion market is forecast to reach $8.5 billion by 2026. In 2019, the market was at $6.9 billion.
2. Key growth drivers include the rising aging population, increased workload and complexity in work structure and advancing technological advancements in healthcare.
3. Older people are the primary patients for spinal fusion. However, the report points to work-from-home arrangements as a primary reason for younger adults to seek spinal fusion treatments.
4. The report profiled six medtech companies in the market: Johnson & Johnson, Alphatec, Globus Medical, Orthofix, Zimmer Biomet and NuVasive.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
